文献速递脊柱关节炎

MAXIMISE 队列中银屑病关节炎伴中轴表现患者的磁共振成像特征

Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

对 MAXIMISE 试验基线脊柱 MRI 进行再读,识别脊髓进程炎症、炎症后及退行性改变,并用逻辑回归分析这些影像特征对治疗效应的差异预测。结果显示脊髓进程炎症和炎症后改变分别见于 11.1% 和 20.2% 患者,64% 患者至少有一种退行性改变;炎症后改变与 ASAS20、ASAS40 和 BASDAI50 应答较好呈趋势,退行性改变与结局较差呈趋势,均未达统计学显著。

要点

  • 脊髓进程炎症见于 11.1%、炎症后改变见于 20.2% 的 MAXIMISE 基线患者。
  • 64% 患者至少有一种退行性改变,Pfirrmann 分级≥3 级最常见(51.1%)。
  • 炎症后改变与较好应答呈趋势、退行性改变与较差结局呈趋势,均未达统计学显著。

核心结论

  • 本次分析发现提示中轴型银屑病关节炎(axPsA)的额外炎症和炎症后改变,并观察到接受司库奇尤单抗治疗患者临床结局较好的趋势。

研究设计与样本

  • 对 MAXIMISE 试验的基线脊柱 MRI 进行再读,以识别额外的炎症(脊髓进程)、炎症后和退行性改变,并使用逻辑回归模型研究这些影像特征的差异治疗效应。

主要发现

  • 除主要分析评估的骨髓水肿外,经 FAt 脊柱关节炎脊柱评分评估的脊髓进程炎症和炎症后改变分别见于 11.1% 和 20.2% 的患者。
  • 至少一种退行性改变见于 64% 的患者,其中 Pfirrmann 分级≥3 级(51.1%)最常见。
  • 结合主要分析和再读 MRI 结果,67.1% 的患者存在炎症或炎症后改变,而 21.2% 的患者仅有退行性改变。
  • 炎症后改变与 ASAS20、ASAS40 和 BASDAI50 应答方面较好疗效结局的趋势相关,但未达统计学显著。
  • 存在退行性改变时观察到结局较差的趋势,但未达统计学显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The current analysis of the MAXIMISE trial was conducted to investigate the presence of post-inflammatory and degenerative spinal changes and inflammatory changes in spinal processes identified in baseline MRIs and their potential for predicting differential treatment effects in a cohort of PsA patients with axial manifestations. METHODS: Baseline spinal MRIs from the MAXIMISE trial were re-read to identify additional inflammatory (spinal process), post-inflammatory, and degenerative changes, and investigate the differential treatment effect of these imaging features using logistic regression modelling. RESULTS: In addition to bone marrow oedema assessed at primary analysis, spinal process inflammation and post-inflammatory changes evaluated by FAt Spondyloarthritis Spine Score were documented in 11.1% and 20.2% patients, respectively. At least one type of degenerative change was noted in 64% patients, with Pfirrmann grade ≥3 (51.1%) being the most common. Combining primary and re-read MRI findings, 67.1% of patients presented with inflammatory or post-inflammatory changes while 21.2% had degenerative changes alone. Although not statistically significant, post-inflammatory changes were associated with a trend for better efficacy outcomes in terms of ASAS20, ASAS40 and BASDAI50 responses; a trend for worse outcomes was observed in the presence of degenerative changes. CONCLUSION: The current analysis revealed the occurrence of additional inflammatory and post-inflammatory changes suggestive of axial PsA (axPsA) and a trend for better clinical outcomes for patients treated with secukinumab. These results elucidate the imaging characteristics and improve our current understanding of axPsA thereby supporting the interpretation of future trials. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02721966.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Baraliakos X, Pournara E, Coates LC, et al. Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort. Rheumatology (Oxford). 2024. PMID: 37094184. doi:10.1093/rheumatology/kead162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。